Cargando…

Editorial: Bioactive sphingolipids in health and disease

Detalles Bibliográficos
Autores principales:	Aslan, Mutay, Oztas, Yesim, Silva, Liana C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593311/ https://www.ncbi.nlm.nih.gov/pubmed/36304920 http://dx.doi.org/10.3389/fmolb.2022.1051449

Ejemplares similares

Editorial: Investigating the impact of bioactive metabolites and extracts in human health and disease
por: Kumar, Sanjeev, et al.
Publicado: (2023)

Editorial: Alternative Splicing in Health and Disease
por: Kahraman, Abdullah, et al.
Publicado: (2022)

Editorial: The Role of Calcium Channels in Human Health and Disease
por: Zhang, Peng, et al.
Publicado: (2022)

Editorial: Molecular determinants of protein assemblies in health and disease
por: Kroschwald, Sonja, et al.
Publicado: (2022)

Editorial: Exploring circular RNAs and their applications within health and disease
por: Becatti, Matteo, et al.
Publicado: (2023)

Editorial: Interaction of Biomolecules and Bioactive Compounds With the SARS-CoV-2 Proteins: Molecular Simulations for the Fight Against Covid-19
por: Falconi, Mattia, et al.
Publicado: (2022)

Editorial: The role of calcium channels in human health and disease—Volume II
por: Zhang, Peng, et al.
Publicado: (2023)

Editorial: Advances in the therapeutic targeting of human matrix metalloproteinases in health and disease
por: Bharadwaj, Shiv, et al.
Publicado: (2023)

Machine learning-enhanced insights into sphingolipid-based prognostication: revealing the immunological landscape and predictive proficiency for immunomotherapy and chemotherapy responses in pancreatic carcinoma
por: Shi, Ting, et al.
Publicado: (2023)

Editorial: the role of mitochondrial endoplasmic reticulum contact sites in human health and disease
por: Katti, Prasanna, et al.
Publicado: (2023)

Advanced bioactive nanomaterials for diagnosis and treatment of major chronic diseases
por: Liu, Yongfei, et al.
Publicado: (2023)

Editorial: Impact of genome instability on human health
por: Ray, Swagat, et al.
Publicado: (2023)

Editorial: Extracellular Vesicles in CNS Diseases
por: Soleti, Raffaella, et al.
Publicado: (2022)

Editorial: Casein kinases in human diseases
por: Venerando, Andrea, et al.
Publicado: (2022)

Editorial: Molecular chaperones and human disease
por: Chakafana, Graham, et al.
Publicado: (2022)

Editorial: Emerging 3D and Animal Models in Diseases and Therapeutics
por: Teng, Yong, et al.
Publicado: (2022)

Editorial: Synthetic Live Biotherapeutic Products for Diseases
por: Chen, Ye, et al.
Publicado: (2022)

Editorial: Cell-Matrix Mechanobiology in Diseases and Development
por: Shokeen, Bhumika, et al.
Publicado: (2022)

Editorial: Innovation and transformation of chronic airway diseases
por: Zhao, Rui, et al.
Publicado: (2022)

Editorial: Small non-coding RNAs in diseases
por: Zhang, Ke, et al.
Publicado: (2023)

Editorial: TGF-β signalling pathways and their enigmatic role as a friend and foe in human health and diseases
por: Betapudi, Venkaiah, et al.
Publicado: (2023)

Aquaporins as Targets of Dietary Bioactive Phytocompounds
por: Tesse, Angela, et al.
Publicado: (2018)

Editorial: BET proteins in chromatin architecture, transcription and disease
por: Singh, Amit Kumar, et al.
Publicado: (2022)

Editorial: Chronic Liver Disease: New Targets and New Mechanisms
por: Ye, Yanting, et al.
Publicado: (2022)

Editorial: “Role of Ribonucleoprotein Complexes in Neurodevelopment and in the Physiopathology of Neurological Diseases”
por: Gwizdek, Carole, et al.
Publicado: (2021)

Editorial: Oligomers in amyloid-associated diseases—structural properties and toxicity
por: Vassallo, Neville, et al.
Publicado: (2023)

Editorial: Reviews in metabolomics: Personalized and predictive medicine of infectious diseases
por: Du Preez, Ilse, et al.
Publicado: (2023)

Editorial: Fibrotic tissue remodeling as a driver of disease pathogenesis
por: Basak, Trayambak, et al.
Publicado: (2023)

Editorial: Recent breakthroughs in the decoding of circulating nucleic acids and their applications to human diseases
por: El-Daly, Sherien M., et al.
Publicado: (2023)

Editorial: RNA Diseases in Humans—From Fundamental Research to Therapeutic Applications
por: Kataoka, Naoyuki, et al.
Publicado: (2019)

Editorial: Molecular Mechanisms Involved in Heart Failure, Parkinson’s, and Alzheimer’s Diseases
por: Femminella, Grazia Daniela, et al.
Publicado: (2021)

Editorial: AI and Multi-Omics for Rare Diseases: Challenges, Advances and Perspectives
por: Bottini, Silvia, et al.
Publicado: (2021)

Editorial: Computational Approaches to Study the Impact of Mutations on Disease and Drug Resistance
por: Ben-Tal, Nir, et al.
Publicado: (2021)

Editorial: Advances in Alzheimer’s disease diagnostics, brain delivery systems, and therapeutics
por: Iyaswamy, Ashok, et al.
Publicado: (2023)

Editorial: Mechanisms of Novel Drugs and Gene Modifiers in the Treatment of Cystic Fibrosis
por: Veit, Guido, et al.
Publicado: (2022)

Editorial: Sulfation Pathways—There and Back Again
por: Mueller, Jon Wolf, et al.
Publicado: (2022)

Editorial: Oncolytic virotherapy
por: Al-Shammari, Ahmed Majeed, et al.
Publicado: (2023)

Editorial: Novel Molecular Mechanisms and Innovative Therapeutic Approaches for Age-Associated Diseases
por: Sun, Leming, et al.
Publicado: (2022)

Editorial: New Insights Into Oxidative Stress and Inflammation in the Pathophysiology and Treatment of Cardiovascular Diseases
por: Becatti, Matteo, et al.
Publicado: (2022)

Editorial: Chronic Liver Disease: New Targets and New Mechanisms, Volume II
por: Jerez, Sofia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0371reccrrp9i03e2letcadpl2